BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8422116)

  • 1. Microglandular adenosis, apocrine adenosis, and tubular carcinoma of the breast. An immunohistochemical comparison.
    Eusebi V; Foschini MP; Betts CM; Gherardi G; Millis RR; Bussolati G; Azzopardi JG
    Am J Surg Pathol; 1993 Feb; 17(2):99-109. PubMed ID: 8422116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomyoepithelioma of the breast with a distinctive type of apocrine adenosis.
    Eusebi V; Casadei GP; Bussolati G; Azzopardi JG
    Histopathology; 1987 Mar; 11(3):305-15. PubMed ID: 2828217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tubular apocrine adenoma and papillary eccrine adenoma. Entities or unity?
    Fox SB; Cotton DW
    Am J Dermatopathol; 1992 Apr; 14(2):149-54. PubMed ID: 1566975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases.
    Wong TY; Suster S; Cheek RF; Mihm MC
    Am J Dermatopathol; 1996 Apr; 18(2):124-36. PubMed ID: 8739986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An immunohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation.
    Ansai S; Koseki S; Hozumi Y; Kondo S
    Am J Dermatopathol; 1995 Jun; 17(3):249-55. PubMed ID: 8599433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apocrine adenocarcinoma of the bilateral axillae.
    Yoshida A; Kodama Y; Hatanaka S; Takasaki T; Kuriwaki K; Yoshida H
    Acta Pathol Jpn; 1991 Dec; 41(12):927-32. PubMed ID: 1785351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of benign and malignant papillary lesions of the breast.
    Papotti M; Eusebi V; Gugliotta P; Bussolati G
    Am J Surg Pathol; 1983 Jul; 7(5):451-61. PubMed ID: 6351647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringocystadenoma papilliferum of the male breast.
    Nowak M; Pathan A; Fatteh S; Fatteh S; Lopez J
    Am J Dermatopathol; 1998 Aug; 20(4):422-4. PubMed ID: 9700386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of gross cystic disease fluid protein (GCDFP-15) in 65 benign sweat gland tumors of the skin.
    Mazoujian G; Margolis R
    Am J Dermatopathol; 1988 Feb; 10(1):28-35. PubMed ID: 2459984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemistry of GCDFP-24 and zinc alpha2 glycoprotein in benign sweat gland tumors.
    Mazoujian G
    Am J Dermatopathol; 1990 Oct; 12(5):452-7. PubMed ID: 2244662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signet ring cells in breast carcinoma. An immunohistochemical and ultrastructural study.
    Yoshida A; Hatanaka S; Oneda S; Yoshida H
    Acta Pathol Jpn; 1992 Jul; 42(7):523-8. PubMed ID: 1329435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spiradenoma and dermal cylindroma: comparative immunohistochemical analysis and histogenetic considerations.
    Meybehm M; Fischer HP
    Am J Dermatopathol; 1997 Apr; 19(2):154-61. PubMed ID: 9129700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.
    Mazoujian G; Pinkus GS; Davis S; Haagensen DE
    Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study.
    Eusebi V; Betts C; Haagensen DE; Gugliotta P; Bussolati G; Azzopardi JG
    Hum Pathol; 1984 Feb; 15(2):134-40. PubMed ID: 6365733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin.
    Wick MR; Lillemoe TJ; Copland GT; Swanson PE; Manivel JC; Kiang DT
    Hum Pathol; 1989 Mar; 20(3):281-7. PubMed ID: 2542151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical localization of gross cystic disease fluid protein-15, -24 and -44 in ductal carcinoma in situ of the breast: relationship to the degree of differentiation.
    Selim AA; El-Ayat G; Wells CA
    Histopathology; 2001 Aug; 39(2):198-202. PubMed ID: 11493337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma.
    Wick MR; Ockner DM; Mills SE; Ritter JH; Swanson PE
    Am J Clin Pathol; 1998 Jan; 109(1):75-84. PubMed ID: 9426521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant eccrine spiradenoma. A clinicopathologic study.
    Argenyi ZB; Nguyen AV; Balogh K; Sears JK; Whitaker DC
    Am J Dermatopathol; 1992 Oct; 14(5):381-90. PubMed ID: 1384379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Presence of alpha-lactalbumin, epidermal growth factor, epithelial membrane antigen, and gross cystic disease fluid protein (15,000 daltons) in breast cyst fluid.
    Collette J; Hendrick JC; Jaspar JM; Franchimont P
    Cancer Res; 1986 Jul; 46(7):3728-33. PubMed ID: 3486713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue.
    Satoh F; Umemura S; Osamura RY
    Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.